MISC

国際誌
2004年4月1日

Effects of sodium tetraborate and boric acid on nonisothermal mannitol crystallization in frozen solutions and freeze-dried solids.

International journal of pharmaceutics
  • Ken-Ichi Izutsu
  • ,
  • Shemaine O Ocheda
  • ,
  • Nobuo Aoyagi
  • ,
  • Shigeo Kojima

273
1-2
開始ページ
85
終了ページ
93
記述言語
英語
掲載種別
DOI
10.1016/j.ijpharm.2003.12.024
出版者・発行元
ELSEVIER SCIENCE BV

The purpose of the present study was to elucidate the effects of sodium tetraborate (borax) and boric acid on the crystallization of mannitol in frozen aqueous solutions and freeze-dried solids. Thermal analysis of frozen solutions showed that sodium tetraborate inhibits mannitol crystallization at sodium tetraborate/mannitol molar concentration ratios of approximately 0.05, which is much lower than the other co-solutes studied (boric acid, sucrose, sodium phosphate buffer). Inhibition of the mannitol crystallization in frozen solutions resulted in highly amorphous mannitol in the freeze-dried solids. Mannitol remained in an amorphous state in some of the combination freeze-dried solids, even at elevated temperatures. Changes in the thermal transition temperatures (glass transition temperature of maximally freeze-concentrated solute ( T'g) and glass transition temperature of freeze-dried solid (Tg)) suggested reduced mannitol molecular mobility with increases in the sodium tetraborate ratio. Fourier-transform infrared spectroscopy (FT-IR) analysis of the bovine serum albumin secondary structure showed apparent protein structure-stabilizing effects of the amorphous mannitol and sodium tetraborate combination during the freeze-drying process. The mannitol and sodium tetraborate combination also protected lactate dehydrogenase (LDH) from inactivation during freeze-drying. We conclude that the complex formation and the accompanying reduction in molecular mobility make sodium tetraborate an effective mannitol crystallization inhibitor in frozen solutions and freeze-dried solids.

リンク情報
DOI
https://doi.org/10.1016/j.ijpharm.2003.12.024
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/15010133
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000220396100010&DestApp=WOS_CPL
ID情報
  • DOI : 10.1016/j.ijpharm.2003.12.024
  • ISSN : 0378-5173
  • PubMed ID : 15010133
  • Web of Science ID : WOS:000220396100010

エクスポート
BibTeX RIS